ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRGX CARGO Therapeutics Inc

19.09
0.09 (0.47%)
May 10 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 132,546
Bid Price 14.00
Ask Price 30.00
News -
Day High 19.49

Low
13.14

52 Week Range

High
33.92

Day Low 18.82
Company Name Stock Ticker Symbol Market Type
CARGO Therapeutics Inc CRGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.09 0.47% 19.09 17:30:00
Open Price Low Price High Price Close Price Prev Close
18.82 18.82 19.49 19.09 19.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,372 132,546 $ 19.17 $ 2,541,477 - 13.14 - 33.92
Last Trade Time Type Quantity Stock Price Currency
16:02:23 priorref 190 $ 19.09 USD

CARGO Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
784.96M 41.21M - 0 -98.15M -2.38 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CARGO Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRGX Message Board. Create One! See More Posts on CRGX Message Board See More Message Board Posts

Historical CRGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week21.6122.12518.8219.83151,012-2.52-11.66%
1 Month21.3722.2118.2519.58181,487-2.28-10.67%
3 Months22.4333.9218.2525.56325,308-3.34-14.89%
6 Months15.4533.9213.1422.86253,6683.6423.56%
1 Year15.4533.9213.1422.86253,6683.6423.56%
3 Years15.4533.9213.1422.86253,6683.6423.56%
5 Years15.4533.9213.1422.86253,6683.6423.56%

CARGO Therapeutics Description

CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.

Your Recent History

Delayed Upgrade Clock